Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ACI Conglomerated
Chicago, Illinois, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
ACI Conglomerated is a fictional pharmaceutical giant featured as the primary antagonist entity in the 1993 film 'The Fugitive.' The company is depicted as a major industry player developing Provasic, a revolutionary new vascular drug intended to generate billions in revenue. The plot centers on the company's internal corruption, specifically the falsification of clinical trial results to conceal the drug's side effect of severe liver damage. This corporate malfeasance leads to the framing of Dr. Richard Kimble to prevent the exposure of the drug's toxicity and ensure its commercial launch.
- Therapeutic areas
- Cardiovascular
- Modalities
- Small molecule
- Industry
- Pharma
Beyond the preview
Go deeper on ACI Conglomerated.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ACI Conglomerated.